Literature DB >> 12781328

Non-caspase-mediated apoptosis contributes to the potent cytotoxicity of the enediyne antibiotic lidamycin toward human tumor cells.

Zhen Wang1, Qiyang He, Yunyan Liang, Daishu Wang, Yi Yang Li, Diandong Li.   

Abstract

Enediyne antibiotics have been reported to be the most potent cytotoxic antitumor agents. The pathway by which these compounds cleave DNA and induce apoptosis of tumor cells may be different from the caspase-mediated pathways that initiate typical apoptosis. In this report, we studied the apoptosis induced by lidamycin (LDM), a member of the enediyne antibiotic family, and compared the characteristics of LDM-induced apoptosis with those of typical apoptosis induced by mitomycin C or etoposide. Chromatin condensation occurred very rapidly and appeared as speckles in human hepatoma BEL-7402 and breast carcinoma MCF-7 cells after treatment with 1 microM LDM. In addition, co-staining the cells with the mitochondria-specific dye Mitosensor and the DNA-specific dye Hoechst 33342 enabled the visualization of mitochondria in normal control and LDM-treated cells but not in mitomycin C-treated cells. Neither the caspase inhibitor VAD-fmk nor the caspase-3 inhibitor DEVD-fmk was able to inhibit the DNA ladder patterns caused by LDM in BEL-7042 or MCF-7 cells. Smaller fragments of histone H1 cleaved by LDM were detected by SDS-PAGE, indicating that the site of LDM action is the internucleosomal structure. Although caspase-9, caspase-3/7, and caspase-6 activities were increased in BEL-7402 cells, and caspase-7 activity was increased in MCF-7 cells after treatment with 1 microM LDM, this occurred much later, indicating that chromatin condensation reached the maximal level rapidly while caspase activities still remained low. Taken together, these results demonstrate that LDM induced rapid DNA cleavage and chromatin condensation independently of caspase activities; this may contribute to its highly potent cytotoxicity toward tumor cells.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12781328     DOI: 10.1016/s0006-2952(03)00117-5

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Mitotic cell death in BEL-7402 cells induced by enediyne antibiotic lidamycin is associated with centrosome overduplication.

Authors:  Yue-Xin Liang; Wei Zhang; Dian-Dong Li; Hui-Tu Liu; Ping Gao; Yi-Na Sun; Rong-Guang Shao
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

2.  Pharmacokinetics of C-1027 in mice as determined by TCA-RA method.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Mao-Jin Zhou; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-02-07       Impact factor: 5.742

3.  Tissue distribution and excretion of 125I-lidamycin in mice and rats.

Authors:  You-Ping Liu; Quan-Sheng Li; Yu-Rong Huang; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2005-06-07       Impact factor: 5.742

4.  Factor VII light chain-targeted lidamycin shows intensified therapeutic efficacy for liver cancer.

Authors:  Qing Zhang; Xiujun Liu; Shuangshuang Xu; Caihong Li; Yang Zhang; Jie Yang; Junnian Zheng
Journal:  Cancer Biother Radiopharm       Date:  2012-05-31       Impact factor: 3.099

5.  EZH2 mediates lidamycin-induced cellular senescence through regulating p21 expression in human colon cancer cells.

Authors:  Ming-Quan Sha; Xiao-Li Zhao; Liang Li; Li-Hui Li; Yi Li; Tian-Geng Dong; Wei-Xin Niu; Li-Jun Jia; Rong-Guang Shao; Yong-Su Zhen; Zhen Wang
Journal:  Cell Death Dis       Date:  2016-11-24       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.